Literature DB >> 7153476

Gigantism and hyperprolactinemia in polyostotic fibrous dysplasia (Mc Cune--Albright syndrome).

C Polychronakos, G Tsoukas, J R Ducharme, J Letarte, R Collu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7153476     DOI： 10.1007/BF03350521

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  6 in total

1.  Editorial: Albright syndrome: is it coming of age?

Authors:  A M Di George
Journal:  J Pediatr       Date:  1975-12       Impact factor: 4.406

2.  Polyostotic fibrous dysplasia with acromegaly (Albright's syndrome). A case report.

Authors:  D G Powell
Journal:  S Afr Med J       Date:  1976-02-07

3.  McCune-Albright syndrome associated with a functioning pituitary chromophobe adenoma.

Authors:  S K Joishy; L B Morrow
Journal:  J Pediatr       Date:  1976-07       Impact factor: 4.406

4.  Hyperprolactinaemia in a patient with the McCune-Albright Syndrome.

Authors:  D Carr; I K Mathie; A R Manners; C Colman
Journal:  Br J Obstet Gynaecol       Date:  1979-04

5.  Hypersecretion of hypothalamic releasing hormones: a possible explanation of the endocrine manifestations of polyostotic fibrous dysplasia (Albright's syndrome).

Authors:  R Hall; C Warrick
Journal:  Lancet       Date:  1972-06-17       Impact factor: 79.321

6.  Growth hormone excess and sexual precocity in polyostotic fibrous dysplasia (McCune-Albright syndrome): evidence for abnormal hypothalamic function.

Authors:  E S Lightner; R Penny; S D Frasier
Journal:  J Pediatr       Date:  1975-12       Impact factor: 4.406
  6 in total
  10 in total

1.  Polyostotic fibrous dysplasia with gigantism and huge pelvic tumor: a rare case of McCune-Albright syndrome.

Authors:  Kenshi Sakayama; Yoshifumi Sugawara; Teruki Kidani; Taketsugu Fujibuchi; Katsumi Kito; Nozomu Tanji; Atsushi Nakamura
Journal:  Int J Clin Oncol       Date:  2010-09-29       Impact factor: 3.402

2.  Octreotide therapy of growth hormone excess in the McCune-Albright syndrome.

Authors:  S I Sherman; P W Ladenson
Journal:  J Endocrinol Invest       Date:  1992-03       Impact factor: 4.256

3.  Acromegaly, multinodular goiter and silent polyostotic fibrous dysplasia. A variant of the McCune-Albright syndrome.

Authors:  R Abs; A Beckers; F L Van de Vyver; A De Schepper; A Stevenaert; G Hennen
Journal:  J Endocrinol Invest       Date:  1990-09       Impact factor: 4.256

Review 4.  A case of pituitary adenoma associated with McCune-Albright syndrome.

Authors:  S Sakaki; S Yokoyama; K Mamitsuka; M Nakayama; M Goto; J Kuratsu
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

5.  Mammosomatotroph hyperplasia associated with acromegaly and hyperprolactinemia in a patient with the McCune-Albright syndrome. A histologic, immunocytologic and ultrastructural study of the surgically-removed adenohypophysis.

Authors:  K Kovacs; E Horvath; M O Thorner; A D Rogol
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

6.  McCune-Albright syndrome. A case of primary hypogonadism obscured by hyperprolactinemic hypogonadotropic hypogonadism.

Authors:  A L Swislocki; C A Camargo; A R Hoffman
Journal:  West J Med       Date:  1990-12

7.  McCune-Albright syndrome with gigantism and hyperprolactinemia.

Authors:  F Pacini; G Perri; P Bagnolesi; A Cilotti; A Pinchera
Journal:  J Endocrinol Invest       Date:  1987-08       Impact factor: 4.256

Review 8.  Acromegaly and McCune-Albright syndrome.

Authors:  Sylvie Salenave; Alison M Boyce; Michael T Collins; Philippe Chanson
Journal:  J Clin Endocrinol Metab       Date:  2014-02-11       Impact factor: 5.958

9.  Mammosomatotroph adenoma of the pituitary associated with gigantism and hyperprolactinemia. A morphological study including immunoelectron microscopy.

Authors:  I A Felix; E Horvath; K Kovacs; H S Smyth; D W Killinger; J Vale
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

10.  Effects of cyproterone acetate, LHRH agonist and ovarian surgery in McCune-Albright syndrome with precocious puberty and galactorrhea.

Authors:  C Carani; C Pacchioni; A Baldini; D Zini
Journal:  J Endocrinol Invest       Date:  1988-06       Impact factor: 4.256
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.